Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""101560960"" wg kryterium: JN

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 33786
Tytuł:
Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment.
Autorzy:
Zhou H; Center for Energy Metabolism and Reproduction, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; Department of Research and Development, Shenzhen Innovation Immunotechnology Co., Ltd, Shenzhen, China.; Department of Research and Development, Shenzhen Institute for Innovation and Translational Medicine, Shenzhen, China.
Ma Y; Department of Research and Development, Shenzhen Innovation Immunotechnology Co., Ltd, Shenzhen, China.; Department of Research and Development, Shenzhen Institute for Innovation and Translational Medicine, Shenzhen, China.
Liu F; Department of Research and Development, Shenzhen Innovation Immunotechnology Co., Ltd, Shenzhen, China.; Department of Research and Development, Shenzhen Institute for Innovation and Translational Medicine, Shenzhen, China.
Li B; Department of Research and Development, Shenzhen Innovation Immunotechnology Co., Ltd, Shenzhen, China.; Department of Research and Development, Shenzhen Institute for Innovation and Translational Medicine, Shenzhen, China.
Qiao D; Department of Research and Development, Shenzhen Innovation Immunotechnology Co., Ltd, Shenzhen, China.; Department of Research and Development, Shenzhen Institute for Innovation and Translational Medicine, Shenzhen, China.
Ren P; Center for Energy Metabolism and Reproduction, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Wang M; Department of Research and Development, Shenzhen Innovation Immunotechnology Co., Ltd, Shenzhen, China.; Department of Research and Development, Shenzhen Institute for Innovation and Translational Medicine, Shenzhen, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Sep 05; Vol. 14, pp. 1255799. Date of Electronic Publication: 2023 Sep 05 (Print Publication: 2023).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Szczegóły
Tytuł:
Factors influencing immunogenicity and safety of SARS-CoV-2 vaccine in liver transplantation recipients: a systematic review and meta-analysis.
Autorzy:
Luo X; Queen Mary School, Nanchang University, Nanchang, Jiangxi, China.; Department of Gastroenterology, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Lessomo FYN; Department of Cardiology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, China.
Yu Z; Department of Gastroenterology, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Xie Y; Department of Gastroenterology, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Sep 05; Vol. 14, pp. 1145081. Date of Electronic Publication: 2023 Sep 05 (Print Publication: 2023).
Typ publikacji:
Systematic Review
Szczegóły
Tytuł:
Macrophages depletion alleviates lung injury by modulating AKT3/GXP4 following ventilator associated pneumonia.
Autorzy:
Zhu Y; Department of Intensive Care Unit, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, Guangdong, China.
Chen Y; Department of Intensive Care Unit, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, Guangdong, China.
Xie D; Department of Emergency, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xia D; Department of Intensive Care Unit, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, Guangdong, China.
Kuang H; Department of Intensive Care Unit, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, Guangdong, China.
Guo X; Department of Ultrasonography, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, Guangdong, China.
Ning B; Department of Neurosurgery, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, Guangdong, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Sep 05; Vol. 14, pp. 1260584. Date of Electronic Publication: 2023 Sep 05 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Szczegóły
Tytuł:
Toll-like receptors: their roles in pathomechanisms of atopic dermatitis.
Autorzy:
Tamagawa-Mineoka R; Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Sep 05; Vol. 14, pp. 1239244. Date of Electronic Publication: 2023 Sep 05 (Print Publication: 2023).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Szczegóły
Tytuł:
Editorial: Structural modeling and computational analyses of immune system molecules.
Autorzy:
Antunes DA; Department of Biology and Biochemistry, University of Houston, Houston, TX, United States.
Schoeder CT; Institute for Drug Discovery, Faculty of Medicine, Leipzig University, Leipzig, Germany.
Baek M; Department of Biochemistry, University of Washington, Seattle, WA, United States.
Donadi EA; Department of Medicine, Division of Clinical Immunology, Ribeirão Preto Medical School, Ribeirão Preto, SP, Brazil.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Sep 05; Vol. 14, pp. 1274670. Date of Electronic Publication: 2023 Sep 05 (Print Publication: 2023).
Typ publikacji:
Editorial
Opinia redakcyjna
Szczegóły
Tytuł:
Differentially activated B cells develop regulatory phenotype and show varying immunosuppressive features: a comparative study.
Autorzy:
Zheremyan EA; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Ustiugova AS; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Uvarova AN; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Karamushka NM; Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia.
Stasevich EM; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Gogoleva VS; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Bogolyubova AV; Laboratory of Transplantation Immunology, National Medical Research Center for Hematology, Moscow, Russia.
Mitkin NA; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Kuprash DV; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.; Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia.
Korneev KV; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.; Laboratory of Transplantation Immunology, National Medical Research Center for Hematology, Moscow, Russia.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Sep 05; Vol. 14, pp. 1178445. Date of Electronic Publication: 2023 Sep 05 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Szczegóły
Tytuł:
Clinical severity classes in COVID-19 pneumonia have distinct immunological profiles, facilitating risk stratification by machine learning.
Autorzy:
Wiffen L; Research and Innovation Department, Portsmouth Hospitals University National Health Service (NHS) Trust, Portsmouth, United Kingdom.
D'Cruz LG; Research and Innovation Department, Portsmouth Hospitals University National Health Service (NHS) Trust, Portsmouth, United Kingdom.; School of Pharmacy & Biomedical Science, University of Portsmouth, Portsmouth, United Kingdom.
Brown T; Research and Innovation Department, Portsmouth Hospitals University National Health Service (NHS) Trust, Portsmouth, United Kingdom.
Higenbottam TW; AKARI Therapeutics PLC, London, United Kingdom.
Bernstein JA; Department of Internal Medicine, Division of Rheumatology, Allergy and Immunology, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
Campbell C; Ohio State University Medical Centre, Department of Cardiovascular Medicine, Columbus, OH, United States.
Moellman J; Department of Emergency Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
Ghosh D; Department of Internal Medicine, Division of Rheumatology, Allergy and Immunology, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
Richardson C; AKARI Therapeutics PLC, London, United Kingdom.
Weston-Davies W; AKARI Therapeutics PLC, London, United Kingdom.
Chauhan AJ; Research and Innovation Department, Portsmouth Hospitals University National Health Service (NHS) Trust, Portsmouth, United Kingdom.; School of Pharmacy & Biomedical Science, University of Portsmouth, Portsmouth, United Kingdom.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Sep 05; Vol. 14, pp. 1192765. Date of Electronic Publication: 2023 Sep 05 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Szczegóły
Tytuł:
Skeletal muscle fibers produce B-cell stimulatory factors in chronic myositis.
Autorzy:
Carstens PO; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
Müllar LM; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
Wrede A; Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.; Institute of Neuropathology, Saarland University Medical Center and Medical Faculty of Saarland University, Homburg, Germany.
Zechel S; Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
Wachowski MM; Department of Trauma Surgery, Orthopaedics and Plastic Surgery, University Medical Center Göttingen, Göttingen, Germany.
Brandis A; Department of Pathology, Klinikum Region Hannover, Hannover, Germany.; Institute of Pathology and Neuropathology, Medical University Hannover, Hannover, Germany.
Krause S; Friedrich-Baur-Institute, Department of Neurology, Ludwig-Maximilians-University of München, München, Germany.
Zierz S; Department of Neurology, University Hospital Halle/Saale, Halle, Germany.
Schmidt J; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.; Department of Neurology and Pain Treatment, Neuromuscular Center, Center for Translational Medicine, Immanuel Klinik Rüdersdorf, University Hospital of the Brandenburg Medical School Theodor Fontane, Rüdersdorf bei Berlin, Germany.; Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, Rüdersdorf bei, Berlin, Germany.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Sep 05; Vol. 14, pp. 1177721. Date of Electronic Publication: 2023 Sep 05 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Szczegóły
Tytuł:
Prospective assessment of pre-existing and de novo anti-HLA IgE in kidney, liver, lung and heart transplantation.
Autorzy:
Mucha J; Department of General Surgery, Division of Transplantation, Medical University of Vienna, Vienna, Austria.
Cho A; Department of General Surgery, Division of Transplantation, Medical University of Vienna, Vienna, Austria.; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
Weijler AM; Department of General Surgery, Division of Transplantation, Medical University of Vienna, Vienna, Austria.
Muckenhuber M; Department of General Surgery, Division of Transplantation, Medical University of Vienna, Vienna, Austria.
Hofmann AG; Department of General Surgery, Division of Transplantation, Medical University of Vienna, Vienna, Austria.
Wahrmann M; Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria.
Heinzel A; Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria.
Linhart B; Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Gattinger P; Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Valenta R; Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.; Karl Landsteiner University of Health Sciences, Krems, Austria.
Berlakovich G; Department of General Surgery, Division of Transplantation, Medical University of Vienna, Vienna, Austria.
Zuckermann A; Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
Jaksch P; Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.
Oberbauer R; Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria.
Wekerle T; Department of General Surgery, Division of Transplantation, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Sep 05; Vol. 14, pp. 1179036. Date of Electronic Publication: 2023 Sep 05 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Szczegóły
Tytuł:
The influence of methotrexate-related transporter and metabolizing enzyme gene polymorphisms on peri-engraftment syndrome and graft-versus-host disease after haplo-hematopoietic stem cell transplantation in pediatric patients with malignant hematological diseases.
Autorzy:
Ji Q; Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China.
Zhang Y; Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China.
Hu Y; Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China.
Liu L; Department of Medical Affairs, Acornmed Biotechnology Co., Ltd., Tianjin, China.
Cao S; Department of Medical Affairs, Acornmed Biotechnology Co., Ltd., Tianjin, China.
Gao L; Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China.
Li B; Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China.
Tian Y; Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China.
Kong L; Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China.
Wu S; Pediatric Intensive Care Unit, Children's Hospital of Soochow University, Suzhou, China.
Ling J; Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China.
Xiao P; Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China.
Lu J; Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China.
Li J; Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China.
Yao Y; Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China.
Qin J; Department of Medical Affairs, Acornmed Biotechnology Co., Ltd., Tianjin, China.
Hu S; Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Sep 05; Vol. 14, pp. 1229266. Date of Electronic Publication: 2023 Sep 05 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Szczegóły
Tytuł:
Predictive values of immune indicators on respiratory failure in the early phase of COVID-19 due to Delta and precedent variants.
Autorzy:
Nagaoka K; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
Kawasuji H; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
Takegoshi Y; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
Murai Y; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
Kaneda M; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
Kimoto K; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
Morimoto S; Innovation Platform & Office for Precision Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Tani H; Department of Virology, Toyama Institute of Health, Toyama, Japan.
Niimi H; Clinical Research Center for Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
Morinaga Y; Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
Yamamoto Y; Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Sep 04; Vol. 14, pp. 1197436. Date of Electronic Publication: 2023 Sep 04 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Szczegóły
Tytuł:
Relationship between serum iron and blood eosinophil counts in asthmatic adults: data from NHANES 2011-2018.
Autorzy:
Wen J; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China.
Wang C; Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China.
Xia J; Department of Respiratory and Critical Care Medicine, The Third Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China.
Giri M; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China.
Guo S; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Sep 04; Vol. 14, pp. 1201160. Date of Electronic Publication: 2023 Sep 04 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Szczegóły
Tytuł:
Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease.
Autorzy:
Monath TP; Crozet Biopharma LLC, Lexington, MA, United States.; Public Health Vaccines Inc., Cambridge, MA, United States.
Nichols R; Public Health Vaccines Inc., Cambridge, MA, United States.
Feldmann F; Rocky Mountain Veterinary Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States.
Griffin A; Laboratory of Virology, Division of Intramural Studies, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States.
Haddock E; Laboratory of Virology, Division of Intramural Studies, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States.
Callison J; Laboratory of Virology, Division of Intramural Studies, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States.
Meade-White K; Laboratory of Virology, Division of Intramural Studies, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States.
Okumura A; Laboratory of Virology, Division of Intramural Studies, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States.
Lovaglio J; Rocky Mountain Veterinary Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States.
Hanley PW; Rocky Mountain Veterinary Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States.
Clancy CS; Rocky Mountain Veterinary Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States.
Shaia C; Rocky Mountain Veterinary Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States.
Rida W; Biostatistics Consultant, Arlington, VA, United States.
Fusco J; Public Health Vaccines Inc., Cambridge, MA, United States.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Sep 04; Vol. 14, pp. 1216225. Date of Electronic Publication: 2023 Sep 04 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Szczegóły
Tytuł:
Cost-effectiveness analysis of dostarlimab plus carboplatin-paclitaxel as first-line treatment for advanced endometrial cancer.
Autorzy:
You M; Department of Pharmacy, Mindong Hospital Affiliated to Fujian Medical University, Ningde, Fujian, China.
Zeng X; Department of Pharmacy, The Second Hospital of Zhangzhou, Zhangzhou, Fujian, China.
Zhang J; Department of Pharmacy, Mindong Hospital Affiliated to Fujian Medical University, Ningde, Fujian, China.
Huang Y; Department of Pharmacy, Mindong Hospital Affiliated to Fujian Medical University, Ningde, Fujian, China.
Zhang Y; Department of Pharmacy, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
Cai Z; Department of Pharmacy, Mindong Hospital Affiliated to Fujian Medical University, Ningde, Fujian, China.
Hu Y; Department of Pharmacy, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Sep 04; Vol. 14, pp. 1267322. Date of Electronic Publication: 2023 Sep 04 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Szczegóły
Tytuł:
Sequencing-based transcriptome analysis reveals diversification of immune response- and angiogenesis-related expression patterns of early-stage cervical carcinoma as compared with high-grade CIN.
Autorzy:
Kurmyshkina OV; Laboratory of Molecular Genetics of Innate Immunity, Institute of Medicine, Petrozavodsk State University, Petrozavodsk, Russia.
Dobrynin PV; Human Genetics Laboratory, Vavilov Institute of General Genetics of Russian Academy of Sciences, Moscow, Russia.
Kovchur PI; Department of Hospital Surgery, Oncology, Urology, Institute of Medicine, Petrozavodsk State University, Petrozavodsk, Russia.; Hospital Admitting Department, The Republican Oncological Dispensary, Petrozavodsk, Russia.
Volkova TO; Department of Biomedical Chemistry, Immunology and Laboratory Diagnostics, Institute of Medicine, Petrozavodsk State University, Petrozavodsk, Russia.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Sep 04; Vol. 14, pp. 1215607. Date of Electronic Publication: 2023 Sep 04 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Szczegóły
Tytuł:
Reactive oxidative species (ROS)-based nanomedicine for BBB crossing and glioma treatment: current status and future directions.
Autorzy:
Wu D; Department of Radiology, The First People's Hospital of Linping District, Hangzhou, China.
Chen X; Department of Radiology, Tongjiang People's Hospital, Tongjiang, China.
Zhou S; Department of Geriatrics, The Fourth Hospital of Daqing, Daqing, China.
Li B; Department of Radiology, The First People's Hospital of Linping District, Hangzhou, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Sep 04; Vol. 14, pp. 1241791. Date of Electronic Publication: 2023 Sep 04 (Print Publication: 2023).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Szczegóły
Tytuł:
Retraction: Harnessing TRAIL-induced apoptosis pathway for cancer immunotherapy and associated challenges.
Corporate Authors:
Frontiers Editorial Office
Źródło:
Frontiers in immunology [Front Immunol] 2023 Sep 04; Vol. 14, pp. 1285126. Date of Electronic Publication: 2023 Sep 04 (Print Publication: 2023).
Typ publikacji:
Retraction of Publication
Szczegóły
Tytuł:
Retraction: Dysregulation of survivin-targeting microRNAs in autoimmune diseases: new perspectives for novel therapies.
Corporate Authors:
Frontiers Editorial Office
Źródło:
Frontiers in immunology [Front Immunol] 2023 Sep 04; Vol. 14, pp. 1285591. Date of Electronic Publication: 2023 Sep 04 (Print Publication: 2023).
Typ publikacji:
Retraction of Publication
Szczegóły
Tytuł:
Discovering immunoreceptor coupling and organization motifs.
Autorzy:
Reth M; Department of Molecular Immunology, Biology III, Faculty of Biology, University of Freiburg, Freiburg, Germany.; Signaling Research Centers CIBSS and BIOSS, University of Freiburg, Freiburg, Germany.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Sep 04; Vol. 14, pp. 1253412. Date of Electronic Publication: 2023 Sep 04 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Szczegóły
Tytuł:
Early innate immune responses in European sea bass ( Dicentrarchus labrax L.) following Tenacibaculum maritimum infection.
Autorzy:
Ferreira IA; Abel Salazar Institute of Biomedical Sciences (ICBAS), University of Porto, Porto, Portugal.; Interdisciplinary Centre of Marine and Environmental Research (CIIMAR), University of Porto, Porto, Portugal.; Fish Immunology and Vaccinology Group, IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal.; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Peixoto D; Abel Salazar Institute of Biomedical Sciences (ICBAS), University of Porto, Porto, Portugal.; Interdisciplinary Centre of Marine and Environmental Research (CIIMAR), University of Porto, Porto, Portugal.
Losada AP; Departamento de Anatomía, Produción Animal e Ciencias Clínicas Veterinarias, Facultade de Veterinaria, Universidade de Santiago de Compostela, Lugo, Spain.
Quiroga MI; Departamento de Anatomía, Produción Animal e Ciencias Clínicas Veterinarias, Facultade de Veterinaria, Universidade de Santiago de Compostela, Lugo, Spain.
do Vale A; Fish Immunology and Vaccinology Group, IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal.; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Costas B; Abel Salazar Institute of Biomedical Sciences (ICBAS), University of Porto, Porto, Portugal.; Interdisciplinary Centre of Marine and Environmental Research (CIIMAR), University of Porto, Porto, Portugal.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Sep 04; Vol. 14, pp. 1254677. Date of Electronic Publication: 2023 Sep 04 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 33786

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies